Ohio Public Employees Retirement System (OPERS)’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-113,655
Closed -$143K 2329
2025
Q3
$143K Hold
113,655
﹤0.01% 1732
2025
Q2
$127K Sell
113,655
-49,000
-30% -$57K ﹤0.01% 1736
2025
Q1
$129K Buy
162,655
+73,889
+83% +$90.6K ﹤0.01% 1722
2024
Q4
$146K Sell
88,766
-46,100
-34% -$116K ﹤0.01% 1724
2024
Q3
$472K Sell
134,866
-4,500
-3% -$17.5K ﹤0.01% 1410
2024
Q2
$457K Sell
139,366
-8,433
-6% -$36.9K ﹤0.01% 1287
2024
Q1
$1.08M Sell
147,799
-6,379
-4% -$39.5K ﹤0.01% 1114
2023
Q4
$577K Hold
154,178
﹤0.01% 1244
2023
Q3
$327K Buy
154,178
+19,775
+15% +$65.5K ﹤0.01% 1295
2023
Q2
$640K Buy
+134,403
New +$742K ﹤0.01% 1238

Other funds holding FATE